MASS MEDICAL ANGELS
Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the life science community to achieve superior returns for their group, and more clinical innovation for the community.
MASS MEDICAL ANGELS
Social Links:
Industry:
Angel Investment Financial Services Life Science
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Constant Contact Mail Pair Networks Hosting PairNetworks DNS
Similar Organizations
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-03 | Astrocyte Pharmaceuticals | Mass Medical Angels investment in Series A - Astrocyte Pharmaceuticals | 6 M USD |
| 2020-12-07 | Coviu | Mass Medical Angels investment in Venture Round - Coviu | 6 M USD |
| 2018-08-14 | Capillary Biomedical | Mass Medical Angels investment in Seed Round - Capillary Biomedical | 2.89 M USD |
| 2018-06-08 | Astrocyte Pharmaceuticals | Mass Medical Angels investment in Seed Round - Astrocyte Pharmaceuticals | 2.4 M USD |
| 2018-03-21 | Lantos Technologies | Mass Medical Angels investment in Venture Round - Lantos Technologies | 10 M USD |
| 2017-04-04 | Sentien Biotechnologies | Mass Medical Angels investment in Series A - Sentien Biotechnologies | 12 M USD |
| 2014-04-08 | InfoBionic | Mass Medical Angels investment in Series B - InfoBionic | 17 M USD |
| 2014-04-04 | Sentieon | Mass Medical Angels investment in Series A - Sentieon | 3.8 M USD |
| 2014-02-05 | Sialix Cancer Research | Mass Medical Angels investment in Series B - Sialix Cancer Research | 1.2 M USD |
| 2014-02-05 | Siamab Therapeutics | Mass Medical Angels investment in Series B - Siamab Therapeutics | 1.2 M USD |